Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia

Journal of the National Cancer Institute

Volumn 84, Issue 6, 1992, Pages 394-398

  Schiffman, Mark H ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER RISK; DISEASE COURSE; MALIGNANT TRANSFORMATION; NOTE; PATHOGENESIS; PRIORITY JOURNAL; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CANCER; WART VIRUS;

ADOLESCENT; ADULT; CERVIX NEOPLASMS; DNA PROBES, HPV; FEMALE; HUMAN; MIDDLE AGE; PAPILLOMAVIRUS; PREVALENCE; TUMOR VIRUS INFECTIONS;

EID: 0026534384     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/84.6.394     Document Type: Note

References (52)

1. Brinton LA, Hamman RF, Huggins GR, et al: Sexual and reproductive risk factors for invasive squamous cell cervical cancer. JNCI 79:23-30, 1987
2. Durst M, Gissmann L, Ikenberg H, et al: A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 80:3812-3815, 1983
3. Boshart M, Gissmann L, Ikenberg H, et al: A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J 3:1151-1157, 1984
4. Lorincz AT, Temple GF, Kurman RJ, et al: Oncogenic association of specific human papillomavirus types with cervical neoplasia. JNCI 79:671-677, 1987
5. Fuchs PG, Girardi F, Pfister H: Human papillomavirus DNA in normal, metaplastic, preneoplastic and neoplastic epithelia of the cervix uteri. Int J Cancer 41:41-45, 1988
6. McCance DJ, Kopan R, Fuchs E, et al: Human papillomavirus type 16 alters human epithelial cell differentiation in vitro. Proc Natl Acad Sci USA 85:7169-7173, 1988
7. Dyson N, Howley PM, Munger K, et al: The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934-937, 1989
8. Werness BA, Levine AJ, Howley PM: Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248:76-79, 1990
9. Kjaer SK, de Villiers EM, Haugaard BJ, et al: Human papillomavirus, herpes simplex virus and cervical cancer incidence in Greenland and Denmark. A population-based cross-sectional study. Int J Cancer 41:518-524, 1988
10. Villa LL, Franco EL: Epidemiologic correlates of cervical neoplasia and risk of human papillomavirus infection in asymptomatic women in Brazil. J Natl Cancer Inst 81:332-340, 1989
11. Bauer HM, Ting Y, Greer CE, et al: Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 265:472-477, 1991
12. Reeves WC, Brinton LA, Garcia M, et al: Human papillomavirus infection and cervical cancer in Latin America. N Engl J Med 320:1436-1441, 1989
13. Kjaer SK, Engholm G, Teisen C, et al: Risk factors for cervical human papillomavirus and herpes simplex virus infections in Greenland and Denmark: A population-based study. Am J Epidemiol 131:669-682, 1990
14. Ley C, Bauer HM, Reingold A, et al: Determinants of genital human papillomavirus infection in young women. J Natl Cancer Inst 83:997-1003, 1991
15. Campion MJ, McCance DJ, Cuzick J, et al: Progressive potential of mild cervical atypia: Prospective cytological, colposcopic, and virological study. Lancet 2:237-240, 1986
16. Koutsky LA, Holmes KK, Critchlow CW, et al: Incidence of cervical intraepithelial neoplasia grade 2 or 3 among a cohort of women with negative cervical cytologic smears: Role of human papillomavirus infection and other risk factors. N Engl J Med. In press
17. Goldberg GL, Vermund SH, Schiffman MH, et al: Comparison of Cytobrush and cervicovaginal lavage sampling methods for the detection of genital human papillomavirus. Am J Obstet Gynecol 161:1669-1672, 1989
18. Kiviat NB, Koutsky LA, Critchlow CW, et al: Comparison of Southern transfer hybridization and dot filter hybridization for detection of cervical human papillomavirus infection with types 6, 11, 16, 18, 31, 33, and 35. Am J Clin Pathol 94:561-565, 1990
19. Schiffman MH, Bauer HM, Lorincz AT, et al: Comparison of Southern blot hybridization and polymerase chain reaction methods for the detection of human papillomavirus DNA. J Clin Microbiol 29:573-577, 1991
20. Brandsma J, Burk RD, Lancaster WD, et al: Inter-laboratory variation as an explanation for varying prevalence estimates of human papillomavirus infection. Int J Cancer 43:260-262, 1989
21. Bartholoma NY, Adelson MD, Forbes BA: Evaluation of two commercially available nucleic acid hybridization assays for the detection and typing of human papillomavirus in clinical specimens. Am J Clin Pathol 95:21-29, 1991
22. Gravitt P, Hakenewerth A, Stoerker J: A direct comparison of methods proposed for use in widespread screening of human papillomavirus infections. Mol Cell Probes 5:65-72, 1991
23. Bosch FX, Munoz N: Human papillomavirus and cervical neoplasia: A critical review of the available epidemiological evidence. In Human Papillomavirus and Cervical Cancer (Munoz N, Bosch FX, Jensen OM, eds). Lyon: IARC Scientific Publications, 1989, pp 135-151
24. Van Den Brule AJ, Walboomers JM, Du Maine M, et al: Difference in prevalence of human papillomavirus genotypes in cytomorphologically normal cervical smears is associated with a history of cervical intraepithelial neoplasia. Int J Cancer 48:404-408, 1991
25. Young LS, Bevan IS, Johnson MA, et al: The polymerase chain reaction: A new epidemiological tool for investigating cervical human papillomavirus infection. BMJ 298:14-18, 1989
26. Acs J, Hildesheim A, Reeves WC, et al: Regional distribution of human papillomavirus DNA and other risk factors for invasive cervical cancer in Panama. Cancer Res 49:5725-5729, 1989
27. Franco EL: The sexually transmitted disease model for cervical cancer: Incoherent epidemiologic findings and the role of misclassification of human papillomavirus infection. Epidemiology 2:98-106, 1991
28. Morrison EA, Ho GY, Vermund SH, et al: Human papillomavirus infection and other risk factors for cervical neoplasia: A case-control study. Int J Cancer 49:6-13, 1991
29. Lorincz AT, Reid R, Jenson AB, et al: The relative prevalence of 15 major anogenital human papillomaviruses in health and disease. Obstet Gynecol. In press
30. Rosenfeld WD, Vermund SH, Wentz SJ, et al: High prevalence rate of human papillomavirus infection and association with abnormal papanicolaou smears in sexually active adolescents. Am J Dis Child 143:1443-1447, 1989
31. Azocar J, Abad SM, Acosta H, et al: Prevalence of cervical dysplasia and HPV infection according to sexual behavior. Int J Cancer 45:622-625, 1990
32. Moscicki AB, Palefsky J, Gonzales J, et al: Human papillomavirus infection in sexually active adolescent females: Prevalence and risk factors. Pediatr Res 28:507-513, 1990
33. Rohan T, Mann V, McLaughlin J, et al: PCR-detected genital papillomavirus infection: Prevalence and association with risk factors for cervical cancer. Int J Cancer 49:856-860, 1991
34. Kataja V, Syrjanen K, Syrjahen S, et al: Prospective follow-up of genital HPV infections: Survival analysis of the HPV typing data. Eur J Epidemiol 6:9-14, 1990
35. Barnes W, Delgado G, Kurman RJ, et al: Possible prognostic significance of human papillomavirus type in cervical cancer. Gynecol Oncol 29:267-273, 1988
36. Walker J, Bloss JD, Liao SY, et al: Human papillomavirus genotype as a prognostic indicator in carcinoma of the uterine cervix. Obstet Gynecol 74:781-785, 1989
37. Riou G, Favre M, Jeannel D, et al: Association between poor prognosis in early-state invasive cervical carcinomas and non-detection of HPV DNA. Lancet 335:1171-1174, 1990
38. Higgins GD, Davy M, Roder D, et al: Increased age and mortality associated with cervical carcinomas negative for human papillomavirus RNA. Lancet 338:910-913, 1991
39. Kiviat NB, Koutsky LA, Paavonen JA, et al: Prevalence of genital papillomavirus infection among women attending a college student health clinic or a sexually transmitted disease clinic. J Infect Dis 159:293-302, 1989
40. De Villiers EM, Wagner D, Schneider A, et al: Human papillomavirus DNA in women without and with cytological abnormalities: Results of a 5- year follow-up study. Gynecol Oncol 44:33-39, 1992
41. Koutsky LA, Galloway DA, Holmes KK: Epidemiology of genital human papillomavirus infection. Epidemiol Rev 10:122-163, 1988
42. Evans S, Dowling K: The changing prevalence of cervical human papilloma virus infection. Aust N Z J Obstet Gynaecol 30:375-377, 1990
43. De Villiers EM, Wagner D, Schneider A, et al: Human papillomavirus infections in women with and without abnormal cervical cytology. Lancet 2:703-706, 1987
44. Maiman M, Tarricone N, Vieira J, et al: Colposcopic evaluation of human immunodeficiency virus-seropositive women. Obstet Gynecol 78:84-88, 1991
45. Vermund SH, Kelley KF, Klein RS, et al: High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Am J Obstet Gynecol 165:392-400, 1991
46. Jochmus-Kudielka I, Schneider A, Braun R, et al: Antibodies against the human papillomavirus type 16 early proteins in human sera: Correlation of anti-E7 reactivity with cervical cancer. J Natl Cancer Inst 81:1698-1704, 1989
47. Jenison SA, Yu XP, Valentine JM, et al: Evidence of prevalent genital- type human papillomavirus infections in adults and children. J Infect Dis 162:60-69, 1990
48. Roman A, Fife K: Human papillomavirus DNA associated with foreskins of normal newborns. J Infect Dis 153:855-861, 1986
49. Ferenczy A, Bergeron C, Richart RM: Human papillomavirus DNA in fomites on objects used for the management of patients with genital human papillomavirus infections. Obstet Gynecol 74:950-954, 1989
50. Cullen AP, Reid R, Campion M, et al: Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasms. J Virol 65:605-612, 1991
51. Scheffner M. Munger K, Byrne JC, et al: The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci USA 88:5523-5527, 1991
52. Koutsky L: Role of epidemiology in defining events that influence transmission and natural history of anogenital papillomavirus infections. J Natl Cancer Inst 83:978-979, 1991